Popular Locations
- Smilow Cancer Hospital
- Smilow Cancer Hospital Care Center - North Haven
- Smilow Cancer Hospital Care Center - Park Avenue Medical Center
In recent years, our knowledge about hereditary pancreatic cancer and genetic testing has increased. While most pancreatic cancer is not hereditary, an estimated 10 percent of pancreatic cancer is due to a hereditary cause.
Hereditary pancreatic cancer is divided into several categories:
Finding a hereditary explanation for why some people developed pancreatic cancer helps to:
Genetic testing is one way to understand if a person has a hereditary risk for pancreatic cancer. If a person has genetic testing and finds that he or she has hereditary pancreatic cancer, it means he or she was born with an increased risk to develop pancreatic and possibly other cancers. Genetic testing for hereditary pancreatic cancer can look for several hereditary cancer syndromes.
In addition, the result of your genetic testing is important information to share with relatives because they may have also inherited the same increased risk to develop cancer. When a hereditary explanation is found in a family, relatives can then better understand their risk to develop cancer, which can help guide their decisions about cancer screening, prevention, and management.
Screening for pancreatic cancer is often performed as part of a research study because we do not yet understand the best way to screen for pancreatic cancer. However, there is some early evidence that pancreatic cancer screening can be of value and considered for people who have a high risk to develop pancreatic cancer. Our Smilow Cancer Hospital experts can discuss the potential benefits, risks, and limitations of pancreatic cancer screening, as well as research studies for people at increased risk for pancreatic cancer.
Hereditary Cancer Syndromes | Associated Gene(s) | Lifetime Risk of Pancreatic Cancer | Other Cancers at Increased Risks |
---|---|---|---|
Hereditary Breast and Ovarian Cancer Syndrome (HBOC) | BRCA1 BRCA2 |
Up to 10%, risk varies by gene | Breast cancer Ovarian cancer Prostate cancer Melanoma |
Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM) | CDKN2A | Up to 20% | Melanoma |
Familial Adenomatous Polyposis Syndrome (FAP) | APC | 2-4% | Multiple precancerous colon polyps (totaling 20 or more) Colorectal cancer Gastrointestinal cancers |
Lynch Syndrome (Hereditary NonPolyposis Colorectal Cancer or HNPCC) | EPCAM MLH1 MSH2 MSH6 PMS2 |
Up to 10%, risk varies by gene | Colorectal cancer Uterine and ovarian cancer Gastrointestinal cancers Urinary tract cancer Sebaceous cancer |
Peutz-Jeghers Syndrome (PJS) | STK11 | Up to 36% | Gastrointestinal tract polyps Gastrointestinal cancers Colorectal cancer Breast cancer Gynecological cancers |
Other Pancreatic Cancer Syndromes | ATM PALB2 | 5-10% | Female breast cancer Ovarian cancer Possible prostate cancer |
Hereditary Pancreatitis and Pancreatic Cancer Syndromes | Associated Gene(s) | Lifetime Risk of Pancreatic Cancer | Other Increased Risks |
---|---|---|---|
Hereditary Pancreatitis (HP) | PRSS1 SPINK1 |
25-40% | Multiple events of severe pancreatitis |
Cystic Fibrosis (CF) | CFTR | Not as well defined | Chronic lung and pancreatic disease |